The global bipolar disorder treatment market is expected to grow steadily through 2032, driven by increasing diagnosis rates, personalized medications, AI-enabled diagnostics, long‑acting injectables (LAIs), and integrated digital therapeutics. North America currently accounts for the largest share, while Asia‑Pacific is the fastest‑growing region due to rising mental health awareness... https://www.uniprismmarketresearch.com/verticals/healthcare/bipolar-disorder-treatment